Prognostic value of pathogenetic therapy-induced changes in NT-proBNP in patients with chronic heart failure
Aim. To study the prognostic value of therapy-induced changes in plasma NT-proBNP levels in patients with left ventricular (LV) systolic dysfunction. Subjects and methods. The study covered 84 patients aged 23 to 70 years (mean 54±8.1 years) with LV systolic dysfunction (an ejection fraction of
Main Authors: | E M Mezhonov, S V Shalaev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2012-09-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31122 |
Similar Items
-
Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
by: Li H, et al.
Published: (2020-02-01) -
The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01) -
The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic
by: Lucian MURESAN, et al.
Published: (2017-06-01) -
Prognostic value of the combination of uric acid and NT-proBNP in patients with chronic heart failure
by: Gülsüm Meral Yılmaz Öztekin, et al.
Published: (2022-05-01) -
NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
by: Claire Sweeney, et al.
Published: (2021-12-01)